Science Applications International (SAIC) Stock Gains As Higher Guidance Meets Soft Bookings

Science Applications International stock inched up 1.8% to US$128.22 after earnings, a calm move for a contractor that just posted another quarter of solid cash and margin execution. The headline is simple: management lifted full year revenue and profit guidance again while keeping at least US$600m of free cash flow on the table.

The short term read is that the market was already leaning optimistic after a strong three month and ninety day run. The longer view now turns to whether the raised margin outlook and the Project ORBIT cost program can support that optimism over the coming years.

Love Science Applications International's steady free cash flow and margin focus but want more ideas with strong balance sheets and cash generation? Take a look at our list of solid balance sheet and fundamentals stocks (52 results).

Q2 2027 Earnings Summary

• Revenue (Q2 2027 vs. Q2 2026): US$1,880m vs. US$1,769m (up about 6.3%)
• Net Income (Excl. Extra Items, Q2 2027 vs. Q2 2026): US$102m vs. US$127m (down about 19.7%)
• Basic EPS (Q2 2027 vs. Q2 2026): US$2.41 vs. US$2.72 (down about 11.5%)
• Adjusted EBITDA Margin (Q2 2027 vs. prior quarter commentary): 10.3% in Q2 2027, in line with the raised full year margin guidance midpoint of 10.3% to 10.5%

Prefer clear visuals instead of scrolling through endless earnings tables and guidance updates? See Science Applications International's full balance sheet and cash flow picture laid out in easy charts and tiles in our company report for Science Applications International.

Science Applications International: Testing The Profitability Upgrade Story

Bulls argue Science Applications International can turn a large federal backlog and a higher quality contract mix into a more profitable, cash rich business. This quarter gives some concrete progress against that script. Revenue of US$1.9b and roughly 5% organic growth show that previously won defense and intel programs are now flowing through, with on-contract growth of 9% and management calling out about US$240m of contribution year to date from recent wins. That supports the idea of multi-year revenue visibility rather than one-off spikes.

The more ambitious part of the bull case sits in margins. Adjusted EBITDA margin of 10.3% already matches the raised full year midpoint, and full year guidance is nudged higher even while management plans heavier second half investment. Project ORBIT is still early, but the reaffirmed US$600m plus free cash flow guide suggests current efficiency and cash conversion are holding up while that work ramps.

Access the full street playbook on when this calm price action could give way to a sharper move, and see where the multi year revenue and earnings curves start to diverge in the analyst estimates for Science Applications International.

Science Applications International: Bear Fears On Growth And Bookings

The bearish view is that Science Applications International cannot turn contract wins into sustained growth and that recompete and procurement risk will eventually show up in weaker numbers. Q2 gives bears some support on bookings. Book to bill of 0.6x and 0.8x on a trailing 12 month basis point to slower award timing and raise questions about how quickly the current backlog will refill. Management flagged delayed recompetes and slower request for proposal cycles, which aligns with worries about a tougher government buying backdrop.

Revenue grew around 5% organically and on-contract growth reached 9%, helped by about US$240m of contribution year to date from recent wins. That progress works against the idea of an immediate growth air pocket. However, the lowered second half margin profile and nonrecurring 1% material benefit mean bears can argue that sustaining Q1 style strength is still unproven.

Review whether Science Applications International's high debt and softer bookings are early warning signs by letting our work surface the risk analysis for Science Applications International which shows 1 important warning sign.

Stay Ahead Of Your Next Move

If Science Applications International's steady free cash flow focus and updated guidance have your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how sentiment reacts to future earnings and booking trends. Once you own or are considering multiple positions, use the Portfolio Command Center to cut through noise and see only the most important developments across your holdings. For a broader view on what other investors are thinking, turn to the Community and compare your thesis with real world perspectives. By surfacing potential catalysts and risks early, Simply Wall St aims to help you stay informed about the market and make decisions with greater confidence.

Curious About Alternatives Beyond Science Applications International

Fresh stock ideas can move quickly once momentum builds. Spot potential breakouts and stocks dropping off the radar before the crowd, while the information still matters. Get in early.

• Spot resilient cash generators that aim to hold up when volatility hits by scanning our curated 74 resilient stocks with low risk scores before others catch on and prices start flying.
• Chase fast-growing themes with real earnings power by checking hand-picked 74 profitable AI stocks that aren't just burning cash that tie excitement to hard numbers instead of hopes and hype.
• Hunt for strong balance sheets that can weather shocks by reviewing a tight shortlist of 39 power grid technology and infrastructure stocks quietly building long term infrastructure stories under the radar for now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com